메뉴 건너뛰기




Volumn 71, Issue 3, 2008, Pages 501-505

Prostate-Specific Antigen Doubling Time Is a Reliable Predictor of Imageable Metastases in Men with Biochemical Recurrence After Radical Retropubic Prostatectomy

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 40649110545     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.10.012     Document Type: Article
Times cited : (17)

References (18)
  • 1
    • 0034817278 scopus 로고    scopus 로고
    • Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy
    • Han M., Partin A.W., Pound C.R., et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. Urol Clin North Am 28 (2001) 555-565
    • (2001) Urol Clin North Am , vol.28 , pp. 555-565
    • Han, M.1    Partin, A.W.2    Pound, C.R.3
  • 2
    • 25144458366 scopus 로고    scopus 로고
    • Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("Trifecta")
    • Bianco F.J., Scardino P.T., and Eastham J.A. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("Trifecta"). Urology 66 (2005) 83-94
    • (2005) Urology , vol.66 , pp. 83-94
    • Bianco, F.J.1    Scardino, P.T.2    Eastham, J.A.3
  • 3
    • 4143053657 scopus 로고    scopus 로고
    • Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results
    • Roehl K.A., Han M., Ramos C.G., et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 172 (2004) 910-914
    • (2004) J Urol , vol.172 , pp. 910-914
    • Roehl, K.A.1    Han, M.2    Ramos, C.G.3
  • 4
    • 78649365001 scopus 로고    scopus 로고
    • Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy
    • D'Amico A.V., Moul J., Carrol P.R., et al. Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy. J Urol 172 (2004) S42-S47
    • (2004) J Urol , vol.172
    • D'Amico, A.V.1    Moul, J.2    Carrol, P.R.3
  • 5
    • 0034815025 scopus 로고    scopus 로고
    • Radical retropubic prostatectomy
    • Lepor H. Radical retropubic prostatectomy. Urol Clin North Am 28 (2001) 509-519
    • (2001) Urol Clin North Am , vol.28 , pp. 509-519
    • Lepor, H.1
  • 6
    • 0141784082 scopus 로고    scopus 로고
    • Contemporary evaluation of operative parameters and complications related to open radical retropubic prostatectomy
    • Lepor H., and Kaci L. Contemporary evaluation of operative parameters and complications related to open radical retropubic prostatectomy. Urology 62 (2003) 702-706
    • (2003) Urology , vol.62 , pp. 702-706
    • Lepor, H.1    Kaci, L.2
  • 7
    • 0033526309 scopus 로고    scopus 로고
    • Natural history of progression after PSA elevation following radical prostatectomy
    • Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591-1597
    • (1999) JAMA , vol.281 , pp. 1591-1597
    • Pound, C.R.1    Partin, A.W.2    Eisenberger, M.A.3
  • 8
    • 0036783942 scopus 로고    scopus 로고
    • A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for therapeutic radiation and oncology criteria
    • Gretzer M.B., Trock B.J., Han M., et al. A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for therapeutic radiation and oncology criteria. J Urol 168 (2002) 1419-1422
    • (2002) J Urol , vol.168 , pp. 1419-1422
    • Gretzer, M.B.1    Trock, B.J.2    Han, M.3
  • 9
    • 0038170185 scopus 로고    scopus 로고
    • Pathology of prostatic neoplasia
    • Walsh P.C., Retik A.B., Vaughn Jr. E.D., et al. (Eds), WB Saunders, Philadelphia
    • Epstein J.I. Pathology of prostatic neoplasia. In: Walsh P.C., Retik A.B., Vaughn Jr. E.D., et al. (Eds). Campbell's Urology. 8th ed. (2002), WB Saunders, Philadelphia 3025-3037
    • (2002) Campbell's Urology. 8th ed. , pp. 3025-3037
    • Epstein, J.I.1
  • 10
    • 0032323478 scopus 로고    scopus 로고
    • Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy
    • Cher M.L., Bianco Jr. F.J., Lam J.S., et al. Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. J Urol 160 (1998) 1387-1391
    • (1998) J Urol , vol.160 , pp. 1387-1391
    • Cher, M.L.1    Bianco Jr., F.J.2    Lam, J.S.3
  • 11
    • 20144374797 scopus 로고    scopus 로고
    • Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy
    • Dotan Z.A., Bianco Jr. F.J., Rabbani F., et al. Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. J Clin Oncol 23 (2005) 1962-1968
    • (2005) J Clin Oncol , vol.23 , pp. 1962-1968
    • Dotan, Z.A.1    Bianco Jr., F.J.2    Rabbani, F.3
  • 12
    • 22844434877 scopus 로고    scopus 로고
    • Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
    • Freedland S.J., Humphreys E.B., Mangold L.A., et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294 (2005) 433-439
    • (2005) JAMA , vol.294 , pp. 433-439
    • Freedland, S.J.1    Humphreys, E.B.2    Mangold, L.A.3
  • 13
    • 11144355828 scopus 로고    scopus 로고
    • Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
    • Stephenson A.J., Shariat S.F., Zelefsky M.J., et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 291 (2004) 1325-1332
    • (2004) JAMA , vol.291 , pp. 1325-1332
    • Stephenson, A.J.1    Shariat, S.F.2    Zelefsky, M.J.3
  • 14
    • 24944522405 scopus 로고    scopus 로고
    • Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates
    • Pazona J.F., Han M., Hawkins S.A., et al. Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates. J Urol 174 (2005) 1282-1286
    • (2005) J Urol , vol.174 , pp. 1282-1286
    • Pazona, J.F.1    Han, M.2    Hawkins, S.A.3
  • 15
    • 0035865443 scopus 로고    scopus 로고
    • Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy
    • Leventis A.K., Shariat S.F., Kattan M.W., et al. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol 19 (2001) 1030-1039
    • (2001) J Clin Oncol , vol.19 , pp. 1030-1039
    • Leventis, A.K.1    Shariat, S.F.2    Kattan, M.W.3
  • 16
    • 2442562364 scopus 로고    scopus 로고
    • Predictors of metastatic disease in men with biochemical failure following radical prostatectomy
    • Okotie O.T., Aronson W.J., Wieder J.A., et al. Predictors of metastatic disease in men with biochemical failure following radical prostatectomy. J Urol 171 (2004) 2260-2264
    • (2004) J Urol , vol.171 , pp. 2260-2264
    • Okotie, O.T.1    Aronson, W.J.2    Wieder, J.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.